TY  - CHAP
M1  - Book, Section
TI  - Chapter 13. Pharmacogenomics in Oncology
A1  - Ikediobi, Ogechi
A1  - Nangia, Julie
A1  - Trivedi, Meghana V.
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
Y1  - 2013
N1  - 
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - Define  and  explain  carcinogenesis  and  cancer  genetics.Identify  the  most  common  germline  variants  and  describe  how  these  can  modulate  treatment  outcome.Describe  how  somatic  variants  can  predict  drug  response.Discuss  pharmacogenomics  in  oncology  clinical  trials.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56877193
ER  -